This week, clinicians report another possible ocular manifestation of COVID-19, the FDA approves new drugs for dry eye and pediatric vernal keratoconjuncitivitis, and researchers propose a new mechanism to treat retinal diseases. Source: AAO
This study assessed visual field outcomes in patients undergoing selective laser trabeculoplasty (SLT) versus medical therapy as a first-line treatment for ocular hypertension and glaucoma. Source: AAO
This retrospective analysis aimed to quantitatively characterize aggressive posterior retinopathy of prematurity in a large cohort. Source: AAO
Researchers assessed the long-term outcomes of uveitic glaucoma in eyes undergoing systemic therapy or fluocinolone acetonide implant. Source: AAO
This week, the second-generation Kahook Dual Blade is set to hit U.S. markets, pegcetacoplan appears to slow geographic atrophy and a new light-sensing protein offers hope for people with degenerative retinal diseases. Source: AAO
Investigators measured macular thickness changes after lens removal and anterior vitrectomy for cataract in pediatric eyes. Source: AAO
Jeffrey Goldberg, MD, PhD, Blumenkranz Smead professor and chair of ophthalmology at Stanford University, has been elected to the National Academy of Medicine. Source: AAO
This study tracked female authorship trends in ophthalmic literature over a 5-year period. Source: AAO
This study identified risk factors for patients who are lost to follow-up while undergoing treatment for proliferative diabetic retinopathy (PDR). Source: AAO
This week, Bausch acquires a microdose formulation of atropine, an injection of hyaluronic acid leads to severe complications and researchers report SARS-CoV-2 antigens can linger in ocular tissues months after the infection has passed. Source: AAO